The Maryland Proton Treatment Center at the University of Maryland has partnered with WellSpan Health so that WellSpan radiation oncologists can work alongside University of Maryland School of Medicine radiation oncology faculty treating cancer patients at the recent $200 million facility in Baltimore.
WellSpan Health includes six hospitals five cancer centers across Adams, York, Lancaster and Lebanon counties in southern Pennsylvania. The new agreement will benefit patients of all of WellSpan’s cancer centers as well as the cancer program of Franklin County-based Summit Health, a WellSpan collaborative partner.
Under the terms of the agreement, WellSpan physicians will be granted adjunct faculty appointments at the University of Maryland School of Medicine and privileges to treat patients at MPTC.
“We have always envisioned the Maryland Proton Treatment Center as a regional resource, with health care providers from around the area joining together to collaborate, not only for the benefit of individual patients, but also to advance the field of radiation oncology,” said Dr. William F. Regine, MPTC’s executive director and chair of radiation oncology at the UM School of Medicine.